CV Protection by Antihyperglycemic Drugs: Evidence from Clinical Trials

Summary

This article discusses the evidence from clinical trials addressing the reduction of cardiovascular (CV) risk with antihyperglycemic drugs. Specific trials include the UKPDS, ACCORD, RECORD, NAVIGATOR, and ORIGIN trials, as well as a number of ongoing clinical trials examining the CV safety of dipeptidyl peptidase-4 inhibitors.

  • Cardiology Clinical Trials
  • Hypertensive Disease
  • Cardiology & Cardiovascular Medicine
  • Cardiology Clinical Trials
  • Hypertensive Disease
View Full Text